EUVIMEDEUVIMED entdecken
Crossref

Pathological Gambling In A Patient With Parkinson’s Disease And Valproate Response

yıldız değirmenci

Dusunen Adam: The Journal of Psychiatry and Neurological Sciences · 2019

DOI: 10.14744/dajpns.2019.00053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dusunen Adam: The Journal of Psychiatry and Neurological Sciences, 2019. Verfasst von yıldız değirmenci. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium valproate is a well-known antiepileptic agent with multiple mechanisms of action such as sodium channel blockage and gamma-aminobutyric acid activity induction.Despite its well-described anxiolytic and mood stabilization effects, its mechanism of action in pathological gambling is not clear.However, it has been reported as an effective treatment option in pathological gambling for patients without Parkinson's disease (PD).We presented a male patient with a diagnosis of PD suffering from pathological gambling as an impulse control disorder due to antiparkinsonian drugs who did not respond to drug adjustments but showed complete improvement with sodium valproate, without any worsening in PD symptoms.

Zitieren

APA

değirmenci, Y. (2019). Pathological Gambling In A Patient With Parkinson’s Disease And Valproate Response. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.14744/dajpns.2019.00053

Vancouver

değirmenci Y. Pathological Gambling In A Patient With Parkinson’s Disease And Valproate Response. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. 2019. doi:10.14744/dajpns.2019.00053

BibTeX
@article{deirmenci2019,
  author = {değirmenci, yıldız},
  title = {Pathological Gambling In A Patient With Parkinson’s Disease And Valproate Response},
  journal = {Dusunen Adam: The Journal of Psychiatry and Neurological Sciences},
  year = {2019},
  doi = {10.14744/dajpns.2019.00053}
}
Kostenlos starten →